


Dr. Michael Kim, MD
Dr. Michael Kim, MD is a surgical oncologist in Houston, TX and has over 15 years of experience in the medical field. He graduated from University of North Carolina at Chapel Hill in 2005. He is affiliated with The University of Texas MD Anderson Cancer Center. He is accepting new patients.
Practice
1515 Holcombe Blvd Houston, TX 77030Make an Appointment
At a Glance
- Area of Expertise

Save money with free prescription discounts
Experience Check
Search for experience in a specific area
Insurance Check
Search for your insurance carrier and choose your plan type
Dr. Kim's Reviews
Likelihood to recommend Dr. Kim
5.0
5 Star | 100% | 100% |
4 Star | 0% | 0% |
3 Star | 0% | 0% |
2 Star | 0% | 0% |
1 Star | 0% | 0% |
Leave a review
How was your experience with Dr. Kim?Overall Patient Satisfaction
Likelihood of recommending Dr. Kim to family and friends is 5 out of 5
About Me
biography
Dr. Michael Kim, MD is a surgical oncologist in Houston, TX and has over 15 years of experience in the medical field. He graduated from University of North Carolina at Chapel Hill in 2005. He is affiliated with The University of Texas MD Anderson Cancer Center. He is accepting new patients.Surgical Oncology
General Surgery
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University Of North Carolina At Chapel Hill
Medical School, 2005
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkTumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes, 2019-08-08
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients, 2021-07-11
Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer, 2015-11-11
METTL13 methylation of eEF1A increases translational output to promote tumorigenesis, 2019-01-03
Focus on Breast Cancer
Locations
Practice
Affiliated Hospitals
- Recipient of 1
hospital award
Your trust is our top concern. Learn more.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.